Lushang Freda PharmaceuticalLtd Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?
Apr 16
Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations
Mar 28Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 04A Look At The Fair Value Of Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)
Feb 27CEO
Lushang Freda PharmaceuticalLtd has no CEO, or we have no data on them.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 2.8yrs | CN¥100.00k | no data | |
| Director | 8.9yrs | no data | no data | |
| Independent Director | 2.8yrs | CN¥100.00k | no data | |
| Chairman of the Supervisory Board | 4.3yrs | no data | no data |
3.6yrs
Average Tenure
54yo
Average Age
Experienced Board: 600223's board of directors are considered experienced (3.6 years average tenure).